Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
10/06/1988 | WO1988007377A1 Human tumour-associated antigen |
10/06/1988 | WO1988007375A1 Novel vaccines |
10/06/1988 | WO1988007374A1 Vaccine against brucella abortus |
10/06/1988 | DE3709449A1 Preparation of carrier-bound synthetic peptides for use as antigen in diagnostic tests and for generating a specific immune response |
10/05/1988 | EP0285441A2 Synergistic immunostimulating composition and method |
10/05/1988 | EP0285263A2 Activated RNase L as a marker for virus infections |
10/05/1988 | EP0285173A2 Human carcinoma-associated antigen and antibody binding to the antigen |
10/05/1988 | EP0285143A2 Antihuman pulmonary adenocarcinoma monoclonal antibody |
10/05/1988 | EP0285059A2 Monoclonal antibodies against glycolipid antigens and their use |
10/05/1988 | EP0284898A2 Hinge peptides, process for their preparation and their use in manufacturing synthetic immunogenes |
10/05/1988 | EP0284791A1 DNA and RNA molecules of the western-subtype TBE virus, polypeptides coded by these molecules and their use |
10/05/1988 | CN88101372A Treponema hyodysenteriae antigen and uses therefor |
10/05/1988 | CN87106697A Method of preparing b-hepatitis compound vaccine |
10/05/1988 | CN87100927A Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas |
10/04/1988 | US4775636 Blot overlay assay using colloidal metal particles |
10/04/1988 | US4775625 Excitation with visible light |
10/04/1988 | US4775620 Cytokeratin tumor markers and assays for their detection |
10/04/1988 | CA1242662A1 Modified live pseudorabies viruses, vaccines for pseudorabies disease containing the same, methods for production of same, and methods for use of same |
10/04/1988 | CA1242659A1 Monoclonal antibodies to human colon cancers and method |
10/04/1988 | CA1242658A1 Immunoassay for biologically active human interferon- gamma employing unique monoclonal antibodies |
09/28/1988 | EP0284587A2 Synthetic peptide antigens for the detection of HIV-1 infection |
09/28/1988 | EP0284549A2 Magnetic fluid compositions |
09/28/1988 | EP0284492A1 Peptidic fractions inducing protective antibodies against the bovine leukemia virus, process for obtaining such fractions, their coding sequences and vaccines produced by these fractions |
09/28/1988 | EP0284413A2 Derivative of a fibrinolytic enzyme |
09/28/1988 | EP0284409A2 Active specific immune suppression |
09/28/1988 | EP0284383A1 Synthetic antigens for the detection of aids-related disease caused by LAV-2 |
09/28/1988 | EP0284368A1 Modified protein A |
09/28/1988 | EP0284232A1 Solid phase assay |
09/28/1988 | EP0283882A1 Cloning of malaria-specific DNA sequences: isolation of the 140 Kd protein gene |
09/28/1988 | EP0283840A2 Mycoplasma hyopneumoniae antigen and uses therefor |
09/28/1988 | EP0283829A1 Plasmodium falciparum merozoite antigen peptides |
09/28/1988 | EP0283563A2 Novel derivatives |
09/28/1988 | CN88102026A Chemo-radio-immuno-conjugates |
09/28/1988 | CN88101839A Virus antigen, method for its preparation and its use for diagnostic and therapeutic purposes (vaccines) |
09/27/1988 | US4774320 Synthetic peptide with human interleukin 1 activity |
09/27/1988 | US4774226 Pharmaceutical preparation for the prophylactic treatment of allergies and process for the preparation of said pharmaceutical preparation |
09/27/1988 | US4774086 Process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the Bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine |
09/27/1988 | CA1242401A1 Human monoclonal antibodies to cancer cells |
09/27/1988 | CA1242393A1 Digitalis antibodies, process for the preparation thereof and the use thereof for the therapy of digitalis intoxications |
09/27/1988 | CA1242392A1 Products and methods for treatment of cancer |
09/27/1988 | CA1242391A1 Method for solubilizing microbial coatings and protein complexes |
09/22/1988 | WO1988007089A1 Altered antibodies |
09/22/1988 | WO1988007087A1 Heliothis expression systems |
09/22/1988 | WO1988007082A1 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
09/22/1988 | WO1988007080A2 Transgenic animal cells resistant to viral infection |
09/22/1988 | WO1988007077A1 Method for the generation of antigen-specific t cell lines and therapeutic use thereof |
09/22/1988 | WO1988007062A1 Variable crosslinked polymeric supports |
09/22/1988 | WO1988007058A1 Anti-paratopic antibody as an immunogen |
09/22/1988 | WO1988007057A1 Purified platelet-derived growth factor and methods for purification thereof |
09/22/1988 | WO1988006892A1 Antigenic determinants recognized by antibodies obtained using a pathogenic agent or a derivative thereof that presents a restricted set of antigens |
09/22/1988 | WO1988006891A1 Method for therapy of leukemias and certain other malignancies |
09/21/1988 | EP0283443A2 Process for extracting membrane antigens having immunogenic properties from human neoplastic cells and products thereby obtained |
09/21/1988 | EP0283329A1 Conjugates of a vinca-alkaloid hydrazide bound to an immunoglobulin |
09/21/1988 | EP0283327A2 Peptides with the immunological properties of HIV-2 |
09/21/1988 | EP0283085A1 Adjuvant mixture |
09/21/1988 | EP0282965A2 Treponema hyodysenteriae antigen and uses therefor |
09/21/1988 | EP0282501A1 Regulating animal reproduction |
09/21/1988 | EP0120906B1 Polypeptides useful in vaccination against enteroviruses |
09/21/1988 | CN87104581A Monoclonal antibodies to pseudomonas aeruginosa flagella |
09/20/1988 | US4772685 Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
09/20/1988 | US4772572 Interleukin, immunoassay |
09/20/1988 | US4772552 Monoclonal antibody which recognizes a 200-220 KD antigen on natural killer cells |
09/20/1988 | US4772547 Detection of aids antibodies |
09/20/1988 | US4772466 Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants |
09/20/1988 | US4772465 Method of treating polymicrobial burn wound sepsis with a combination therapy of ciprofloxacin and pseudomonas immune globulin |
09/20/1988 | US4772464 Monoclonal antibodies which inhibit motility of bacteria |
09/14/1988 | EP0282343A2 Method to stimulate the immune response to specific antigens |
09/14/1988 | EP0282317A2 Purified platelet-derived growth factor and methods for purification thereof |
09/14/1988 | EP0282308A2 Immobilized immunoglobulin-binding proteins |
09/14/1988 | EP0282179A2 Canine distemper virus vaccine |
09/14/1988 | EP0282124A2 Method for manufacturing a modular semiconductor power device and device obtained thereby |
09/14/1988 | EP0282057A2 Chemo-radio-immuno-conjugates |
09/14/1988 | EP0281978A2 Inactivation of human immunodeficiency virus (HIV) in proteinic solutions by means of phenol |
09/14/1988 | EP0281922A1 Microspheric bodies and method for detecting therapies of alzheimer's disease and related conditions |
09/14/1988 | EP0281803A1 Immunogenic fusion proteins containing Epstein-Barr virus protein |
09/14/1988 | EP0281673A1 Plasmid for production of membrane protein, bacterium containing same, monoclonal antibody therefore, and method for the identification of haemophilus influenzae |
09/14/1988 | EP0111549B1 Inactivation of a lipid virus |
09/14/1988 | EP0104217B1 Coding dna fragments for polypeptides containing at least one antigenic determinant of the papillomavirus particularly of the la hpv type and corresponding polypeptides |
09/13/1988 | US4771127 Covalently linked through hydroxyl or carboxyl groups; safe, immunogenic |
09/13/1988 | US4770875 Process for preparation of improved mutant strain of Bordetella bronchiseptica useful for live attenuated vaccine for protection of B. bronchiseptica infection and live attenuated AR vaccine produced therefrom |
09/13/1988 | US4770874 Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
09/13/1988 | CA1241949A1 Acid-cleavable compound |
09/13/1988 | CA1241924A1 Antigens and monoclonal antibodies reactive against merozites of eimeria spp |
09/13/1988 | CA1241923A1 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp |
09/13/1988 | CA1241917A1 Oral vaccine for immunization against enteric disease |
09/07/1988 | WO1988006629A1 Polypeptides useful in diagnosis of coccidia infection and recombinant-dna methods for manufacturing same |
09/07/1988 | WO1988006626A1 Recombinant mycobacterial vaccine |
09/07/1988 | WO1988006594A1 Synthetic anti-caries vaccine |
09/07/1988 | WO1988006592A1 Cloning of lfa-1 |
09/07/1988 | WO1988006591A1 Mycobacterial recombinants and peptides |
09/07/1988 | WO1988006455A1 Antibodies against streptococcus |
09/07/1988 | WO1988006454A1 Agent preventing the development of disease after hiv infection |
09/07/1988 | WO1988006452A1 Compositions for enhancing adcc therapy |
09/07/1988 | WO1988006451A1 Immunosuppression in immunotoxin based human therapy |
09/07/1988 | EP0281530A1 Recombinant plasmids useable for the expression of heterologous proteins in bacillus |
09/07/1988 | EP0281070A2 Pharmaceutical composition for the treatment of cancer |
09/07/1988 | EP0280840A1 Methods of preparing biologically active membranes and uses thereof |
09/07/1988 | EP0280813A2 Synthetic polypeptides and antibodies related to Epstein-Barr virus early diffuse antigen |
09/07/1988 | EP0086707B1 Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies |
09/07/1988 | CN88100621A Internal light-activated compounded medicine for cancerociding-immunization |